BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 33838632)

  • 1. Microbial Arsenal of Antiviral Defenses - Part I.
    Isaev AB; Musharova OS; Severinov KV
    Biochemistry (Mosc); 2021 Mar; 86(3):319-337. PubMed ID: 33838632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial Arsenal of Antiviral Defenses. Part II.
    Isaev AB; Musharova OS; Severinov KV
    Biochemistry (Mosc); 2021 Apr; 86(4):449-470. PubMed ID: 33941066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
    Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
    Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage Genetic Engineering Using CRISPR⁻Cas Systems.
    Hatoum-Aslan A
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29921752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revenge of the phages: defeating bacterial defences.
    Samson JE; Magadán AH; Sabri M; Moineau S
    Nat Rev Microbiol; 2013 Oct; 11(10):675-87. PubMed ID: 23979432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
    Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.
    Borges AL; Davidson AR; Bondy-Denomy J
    Annu Rev Virol; 2017 Sep; 4(1):37-59. PubMed ID: 28749735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PADS Arsenal: a database of prokaryotic defense systems related genes.
    Zhang Y; Zhang Z; Zhang H; Zhao Y; Zhang Z; Xiao J
    Nucleic Acids Res; 2020 Jan; 48(D1):D590-D598. PubMed ID: 31620779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary Genomics of Defense Systems in Archaea and Bacteria.
    Koonin EV; Makarova KS; Wolf YI
    Annu Rev Microbiol; 2017 Sep; 71():233-261. PubMed ID: 28657885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of molecular mechanisms used by anti-CRISPR proteins: the tip of an iceberg?
    Hardouin P; Goulet A
    Biochem Soc Trans; 2020 Apr; 48(2):507-516. PubMed ID: 32196554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage-Encoded Anti-CRISPR Defenses.
    Stanley SY; Maxwell KL
    Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In defense of phage: viral suppressors of CRISPR-mediated adaptive immunity in bacteria.
    Wiedenheft B
    RNA Biol; 2013 May; 10(5):886-90. PubMed ID: 23392292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CRISPR-Cas system and coevolution of bacteria and phages].
    Li TM; Du B
    Yi Chuan; 2011 Mar; 33(3):213-8. PubMed ID: 21402528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of phages and bacteria: the co-evolutionary arms race.
    Safari F; Sharifi M; Farajnia S; Akbari B; Karimi Baba Ahmadi M; Negahdaripour M; Ghasemi Y
    Crit Rev Biotechnol; 2020 Mar; 40(2):119-137. PubMed ID: 31793351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of CRISPR-mediated microbial immunity.
    Gasiunas G; Sinkunas T; Siksnys V
    Cell Mol Life Sci; 2014 Feb; 71(3):449-65. PubMed ID: 23959171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Special focus CRISPR-Cas.
    Marchfelder A
    RNA Biol; 2013 May; 10(5):655-8. PubMed ID: 23872677
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-CRISPRs go viral: The infection biology of CRISPR-Cas inhibitors.
    Li Y; Bondy-Denomy J
    Cell Host Microbe; 2021 May; 29(5):704-714. PubMed ID: 33444542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of temperate phages drives loss of type I CRISPR-Cas systems.
    Rollie C; Chevallereau A; Watson BNJ; Chyou TY; Fradet O; McLeod I; Fineran PC; Brown CM; Gandon S; Westra ER
    Nature; 2020 Feb; 578(7793):149-153. PubMed ID: 31969710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abortive Infection: Bacterial Suicide as an Antiviral Immune Strategy.
    Lopatina A; Tal N; Sorek R
    Annu Rev Virol; 2020 Sep; 7(1):371-384. PubMed ID: 32559405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.